Ibsa Inst Bio Drug Patent Portfolio
Ibsa Inst Bio owns 1 orange book drug protected by 2 US patents Given below is the list of Ibsa Inst Bio's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US11344520 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug | 20 Feb, 2035 | Active |
US11351133 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug | 20 Feb, 2035 | Active |
Latest Legal Activities on Ibsa Inst Bio's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ibsa Inst Bio.
Activity | Date | Patent Number |
---|---|---|
Electronic Review
Critical
| 25 May, 2023 | US11351133 |
Mail Certificate of Correction Memo | 24 May, 2023 | US11351133 |
Post Issue Communication - Certificate of Correction | 22 May, 2023 | US11351133 |
Certificate of Correction Memo | 22 May, 2023 | US11351133 |
Recordation of Patent Grant Mailed
Critical
| 07 Jun, 2022 | US11351133 |
Patent Issue Date Used in PTA Calculation
Critical
| 07 Jun, 2022 | US11351133 |
Recordation of Patent Grant Mailed
Critical
| 31 May, 2022 | US11344520 |
Patent Issue Date Used in PTA Calculation
Critical
| 31 May, 2022 | US11344520 |
Email Notification
Critical
| 19 May, 2022 | US11351133 |
Issue Notification Mailed
Critical
| 18 May, 2022 | US11351133 |
Application Is Considered Ready for Issue
Critical
| 13 May, 2022 | US11351133 |
Dispatch to FDC | 13 May, 2022 | US11351133 |
Email Notification
Critical
| 12 May, 2022 | US11344520 |
Issue Notification Mailed
Critical
| 11 May, 2022 | US11344520 |
Email Notification
Critical
| 10 May, 2022 | US11351133 |
Ibsa Inst Bio's Family Patents
Ibsa Inst Bio drugs have patent protection in a total of 1 countries. It has a significant patent presence in the US with 100.0% of its patents being US patents. Click
below to unlock the full patent family tree.
Ibsa Inst Bio Drug List
Given below is the complete list of Ibsa Inst Bio's drugs and the patents protecting them.
1. Licart
Licart is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US11344520 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug |
20 Feb, 2035
(10 years from now)
| Active |
US11351133 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug |
20 Feb, 2035
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Licart's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List